Reneo Pharmaceuticals, Inc. (RPHM)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 07, 2025

$5.85

P/E Ratio

N/A

Market Cap

$19.56M

Description
Add to research

Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.

Metrics
Add to research

Overview

  • HQIrvine, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerRPHM
  • Price$5.85+2.81%

Trading Information

  • Market cap$19.56M
  • Float73.46%
  • Average Daily Volume (1m)118,579
  • Average Daily Volume (3m)116,675
  • EPS-$12.28

Company

  • RevenueN/A
  • Rev growth (1yr)N/A
  • Net income-$3.69M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$4.66M
  • EV-$19.18M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.26
  • Debt/Equity0.90
Documents
Add to research